Related Experiment Video
Updated: Aug 2, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Seizure Management and Prophylaxis Considerations in Patients with Brain Tumors
Nils Stenvågnes Hauff1, Anette Storstein2
1Department of Neurology, Haukeland University Hospital, Jonas Lies Vei 65, 5021, Bergen, Norway. Nils.stenvagnes.hauff@helse-bergen.no.
This review covers managing tumor-related epilepsy, emphasizing individualized treatment. Personalized seizure control is key for brain tumor patients, improving quality of life and treatment efficacy.
Area of Science:
- Neuro-oncology
- Epileptology
Background:
- Epilepsy is a common complication of brain tumors, significantly impacting patient quality of life.
- Current management strategies require optimization for better seizure control and treatment outcomes.
Purpose of the Study:
- To provide an overview of current knowledge in managing tumor-related epilepsy.
- To highlight recent insights into individualized treatment approaches for this patient population.
Main Methods:
- Systematic reviews and consensus statements were analyzed.
- Recent clinical insights and molecular marker data were incorporated.
Main Results:
- Tumor molecular markers (e.g., IDH1 mutation, MGMT methylation) show potential as future treatment targets.
- Seizure control is a critical metric for assessing brain tumor treatment efficacy.
- Prophylactic anti-seizure medication is recommended after the first seizure in brain tumor patients.
Conclusions:
- Individualized seizure prophylactic treatment is essential to minimize adverse effects and maximize seizure freedom.
- Prompt treatment of status epilepticus is crucial due to its association with inferior survival.
- A multidisciplinary team approach is recommended for managing patients with brain tumors and epilepsy.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

